期刊文献+

输血后丙型肝炎11年前瞻性研究 被引量:1

11 YEARS' PROSPECTIVE STUDY ON POST-TRANSFUSION HEPATITIS C CASES
下载PDF
导出
摘要 [目的]研究不同感染类型输血后丙型肝炎病人的转归。[方法]将38例输血后丙型肝炎病人分为急性黄疸型(16例)、急性无黄疸型(16例)和亚临床感染(6例)3组,采用前瞻性研究的方法,检测11年随访期间采集到的血清抗-HCV、HCVRNA和ALT。[结果]38例输血后丙型肝炎,32例为临床型,症状和体征于半年内全部消失。在11年的随访期间,所有病例均未再出现肝炎症状和体征,未发生各种晚期肝病和死亡。38例病人ALT转归存在3种类型:1,一过性异常(黄疸型︰无黄疸型︰亚临床型,6︰8︰0);2,持续异常(0︰3︰0);3,波动性异常(10︰5︰6)。38名病例均未检测到抗-HCV波动和阴转。36例病人检测两次以上HCVRNA,转归存在4种情况:1,阳转后每次检测均保持阳性26例(12︰10︰4);2,阳转后,转为阴性,再转为阳性4例(1︰2︰1);3,阳转后,再转为持续阴性5例(2︰3︰0);4,始终不能检测到HCVRNA(0︰0︰1)。不同临床型HCVRNA阴转率无差异,P﹥0.1。[结论]不同感染类型输血后丙型肝炎病人抗-HCV、HCVRNA和ALT转归相似,ALT持续异常仅见于急性无黄疸型病人,HCVRNA持续阴性仅见于亚临床型感染。 [ Objective] To study the occurrence and prognosis of post-transfusion Hepatitis C cases. [ Methods] 38 post-transfusion Hepatitis C cases were divided into 3 groups according to their symptoms and physical signs of acute stage. The sera of these patients collected during 11 years were tested for anti-HCV, ALT and HCV RNA. [ Results] After acute stage, no patient presented symptom again. No death due to infection of hepatitis C was found. There were 3 types in outcome of the 38 patients: short time abnormal, persistent abnormal, and waving trend abnormal respectively. The outcome of anti-HCV just presented persistent positive. The outcome of HCV RNA included 4 types, which were persistent positive (26 cases), waving trend (4 cases), persistent negative after converting to positive (5 cases), persistent positive ( 1 case) respectively. The rate that HCV RAN in serum changed to negative after converting to positive didn't show difference between jaundice cases and no jaundice cases (P〉 0.1) . [Conclusion] The outcome of ALT, anti-HCV and HCV RNA are similar among cases with different symptoms. Persistent negative HCV RNA is just observed in patients with no symptom. Persistent abnormal ALT just exits in acute non-jaundice patients.
出处 《现代预防医学》 CAS 北大核心 2007年第11期2018-2020,共3页 Modern Preventive Medicine
基金 河北省科技厅科研项目(05360)
关键词 输血 丙型肝炎 谷丙转氨酶 病毒抗体 病毒核酸 Transfusion Hepatitis C ALT Anti-HCV HCV RNA
  • 相关文献

参考文献4

  • 1Cecere A,Marotta F,Lueariello A,et al.High prevalence of hepatitis C virus infection in a southern Italian rural region.Clinical aspects and evidence of inapparent parenteral exposure[J].Panminerva Med,2003,45(4):253-259.
  • 2Harris HE,Ramsay ME,Andrews N,et al.Clinical course of hepatitis C virus during the first decade of infection:cohort study[J].BMJ,2002,324(7335):450-453.
  • 3祁自柏,周诚,扬振,张庶民,谷金莲,李河民.第3代丙肝试剂国家参考品的研制及初步应用[J].中国生物制品学杂志,1999,12(2):103-105. 被引量:15
  • 4Kurosaki M,Enomoto N.Variations in the cole regio of hepatitis C virus genomes in patients with chronic hepatitis[J].Arch Virol,1995,140(6):1087-94.

二级参考文献2

共引文献14

同被引文献11

  • 1金振良,王福成,朱发明.丙型肝炎病毒抗体阴性献血人群中丙型肝炎病毒核心抗原检测的研究[J].中华医院感染学杂志,2005,15(8):859-860. 被引量:5
  • 2郭振华,景涛,陈青锋,杨彦麟,肖萍,陈玉霞.血清HCV RNA检测在慢性丙型肝炎诊断中的意义[J].国外医学(临床生物化学与检验学分册),2005,26(12):953-954. 被引量:1
  • 3崇雨田,林潮双,赵志新,林国莉,李建国,高志良.输血后丙型肝炎患者的临床特点及自然病程[J].中华肝脏病杂志,2006,14(3):199-201. 被引量:11
  • 4Casato M,LiliD, Donato G, et al. Occult hepatitis C virus infection in type Ⅱ mixed cryoglobulinaemia. J Viral Hepatol, 2003, 10: 455-459.
  • 5Castillo I,Pardo M,Bartolome J,et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently ahnorma results of liver-function tests is unknown. J Infect Dis,2004,189:7-14.
  • 6Beld M,Penning M, van Putten M, et al. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undeteetable periods before seroeonversion. Blood, 1999, 94:1183-1191.
  • 7Carreno V,Castillo I,Bartolome J, et al. Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. J Clin Virol, 2004, 31:312-313.
  • 8Lerat H, H ollinger FB. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis, 2004, 189:7-14.
  • 9Pardo M, Lopez-Alcorocho JM, Rodriguez Inigo E, et al. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepatol. 2007,14:36-411.
  • 10Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology:current issues, future challenges. Mol Diagn, 2000,5:11.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部